BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 4258885)

  • 1. [Indications for and hazards of anticoagulant therapy].
    Straub PW
    Schweiz Med Wochenschr; 1970 Apr; 100(16):686-91. PubMed ID: 4258885
    [No Abstract]   [Full Text] [Related]  

  • 2. Anticoagulant therapy: questions and answers.
    Sherry S
    Compr Ther; 1976 Dec; 2(12):58-65. PubMed ID: 1000925
    [No Abstract]   [Full Text] [Related]  

  • 3. [Indications of anticoagulant and fibrinolytic drugs in the prevention and therapy of thromboembolic diseases].
    Verstraete M
    Clin Ter; 1975 Jun; 73(5):403-22. PubMed ID: 1139864
    [No Abstract]   [Full Text] [Related]  

  • 4. A critical evaluation of anticoagulant therapy.
    Wright IS
    Geriatrics; 1969 Mar; 24(3):96-100. PubMed ID: 4885555
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anticoagulant therapy and prophylaxis in arterial vascular diseases].
    Heine H; Schmidt H; Mach H; Jaruszewski H
    Dtsch Gesundheitsw; 1971 May; 26(19):861-8. PubMed ID: 5578165
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic fibrinolysis].
    Straub PW
    Schweiz Med Wochenschr; 1973 May; 103(20):753-7. PubMed ID: 4702993
    [No Abstract]   [Full Text] [Related]  

  • 7. Implications of anticoagulant therapy.
    Ellison N; Jobes DR; Schwartz AJ
    Int Anesthesiol Clin; 1982; 20(4):121-35. PubMed ID: 6757142
    [No Abstract]   [Full Text] [Related]  

  • 8. [Anticoagulant therapy].
    Maragall S; Labal F; Monteagudo J
    Med Clin (Barc); 1984 Mar; 82(9):410-7. PubMed ID: 6371404
    [No Abstract]   [Full Text] [Related]  

  • 9. Anticoagulants in peripheral vascular disease.
    Prentice CR; McNicol GP
    Practitioner; 1971 Mar; 206(233):330-7. PubMed ID: 5555329
    [No Abstract]   [Full Text] [Related]  

  • 10. Effectiveness of anticoagulants.
    Hirsh J
    Semin Thromb Hemost; 1986 Jan; 12(1):21-37. PubMed ID: 3515557
    [No Abstract]   [Full Text] [Related]  

  • 11. Anticoagulant therapy in myocardial infarction.
    Vreeken J
    Compr Ther; 1976 Dec; 2(12):50-2. PubMed ID: 1000924
    [No Abstract]   [Full Text] [Related]  

  • 12. Anticoagulant therapy: a critique.
    Gross H; Hasson J; Solomon S
    Am Fam Physician; 1971 Jun; 3(6):87-91. PubMed ID: 5580625
    [No Abstract]   [Full Text] [Related]  

  • 13. Heparin: an overview.
    Maguire FW
    Del Med J; 1979 Aug; 51(8):439-49. PubMed ID: 385374
    [No Abstract]   [Full Text] [Related]  

  • 14. [Anticoagulant therapy].
    Marx R
    Z Allgemeinmed; 1970 Aug; 46(24):1212-6. PubMed ID: 5512675
    [No Abstract]   [Full Text] [Related]  

  • 15. [Current trends in anticoagulant and thrombolytic therapy of thrombosis].
    Gavrilov OK; Rachinskaia NA; Kaveshnikova BF
    Sov Med; 1975 Sep; (9):53-9. PubMed ID: 781864
    [No Abstract]   [Full Text] [Related]  

  • 16. Anticoagulant treatment of venous thromboembolism.
    Coon WW
    Surg Annu; 1972; 4():151-63. PubMed ID: 4668856
    [No Abstract]   [Full Text] [Related]  

  • 17. [General directions for anticoagulant therapy].
    Cuore Circ; 1970 Feb; 54(1):35-8. PubMed ID: 5448555
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical use of heparin-heparinoid-mixtures].
    Hörder MH; Stier WD; Brunswig D
    Arzneimittelforschung; 1969 Nov; 19(11):1873-6. PubMed ID: 4190000
    [No Abstract]   [Full Text] [Related]  

  • 19. [Advantages and hazards of drug treatment in surgery. Anticoagulants and fibrinolytic agents].
    Gross R
    Chirurg; 1968 May; 39(5):201-8. PubMed ID: 4974339
    [No Abstract]   [Full Text] [Related]  

  • 20. Anticoagulant and thrombolytic drugs. II. Clinical aspects.
    Ogston D; Douglas AS
    Drugs; 1971; 1(4):303-19. PubMed ID: 4939607
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.